The clinical studies for the peritoneal mesothelioma
To try to ensure effective treatment and cure of mesothelioma, the clinical trials were an important part of the process of treatment. These tests, which are among the institutions and hospitals across the country are testing the effectiveness and adverse effects of each drug, which has shown significant improvement in a study as part of the laboratory and in tests on animals.
There is no guarantee that any clinical trial will be successful, indeed, that the treatment already successfully used. The aim of the clinical trial is to determine what kind of impact of new treatments or drugs may have, and then a decision can be made whether the treatment should be at the forefront for approval by the FDA (Food and Drugs Administration).
The clinical tests are based on the drug who have shown good signs of cancer cells react, and the aim of these tests is to monitor, and the reaction to the impact on the people. The nature of the procedures may vary, depending on the condition and the place where it stands.
Some of the recent and clinical trials across the country include:
(1) Alimta & gemcitabine
(2) Neoadjuvant pemetrexed disodium and cisplatin followed by surgery and radiation therapy
(3) Intra pleural mesothelioma BG00001
(4) erlotinib in patients with solid tumors in the liver or / renal dysfunction
(5) PTK787/ZK 222584 for Patients with Unresectable Malignant Mesothelioma
(6) Alanosine
(7) U1 (dsFv) - PE38 Immunotoxin (for patients with advanced cancer)
These reactions are a sample, some of the new and ongoing clinical studies on the operation. There are new experiments and analyses of light on a regular basis, many of which are in clinical trials. And it is through the trials, it is hoped that a breakthrough in the treatment of Mesothelioma comes the light.
